UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 123

Sortiert nach

Sustained Inhibition of Calcineurin Activity With a Melt‐Dose Once‐daily Tacrolimus Formulation in Renal Transplant Recipients

Clinical pharmacology and therapeutics, 2021-07, Vol.110 (1), p.238-247

2021

Volltextzugriff (PDF)

Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy

Frontiers in immunology, 2022-04, Vol.13, p.895209-895209

2022

Volltextzugriff (PDF)

A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction

Kidney international, 2023-10, Vol.104 (4), p.840-850

2023

Volltextzugriff (PDF)

Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation

Frontiers in pharmacology, 2021-03, Vol.12, p.636048

2021

Volltextzugriff (PDF)

The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations

Pharmaceutics, 2023-05, Vol.15 (5), p.1481

2023

Volltextzugriff (PDF)

Estimation of the uncertainty of values assigned to calibration materials prepared in-house: An example for hydroxychloroquine calibrators in blood-hemolysate-based matrix

Clinical biochemistry, 2021-03, Vol.89, p.70-76

2021

Volltextzugriff (PDF)

Measurement uncertainty estimation of free drug concentrations in clinical laboratories using equilibrium dialysis

Clinical chemistry and laboratory medicine, 2024-04, Vol.62 (5), p.870

2024

Volltextzugriff (PDF)

Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial

Frontiers in medicine, 2021-06, Vol.8, p.691712-691712

2021

Volltextzugriff (PDF)

Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients

Antibiotics (Basel), 2023-03, Vol.12 (3), p.531

2023

Volltextzugriff (PDF)

Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection

Journal of antimicrobial chemotherapy, 2018-04, Vol.73 (4), p.1104-1106

2018

Volltextzugriff (PDF)

Traceability of immunosuppressant's mass concentration results obtained using different commercial calibrators

Clinical biochemistry, 2019-01, Vol.63, p.113-120

2019

Volltextzugriff (PDF)

Calculation of reference intervals for the concentrations of α-tocopherol and retinol in serum using indirect data-mining procedures

Clinica chimica acta, 2024-07, Vol.561, p.119822, Article 119822

2024

Volltextzugriff (PDF)

Efficacy of meropenem extended infusion vs intermittent bolus monotherapy and in combination with colistin against Pseudomonas aeruginosa biofilm

International journal of antimicrobial agents, 2023-08, Vol.62 (2), p.106856-106856, Article 106856

2023

Volltextzugriff (PDF)

Reference change values based on uncertainty models

Clinical biochemistry, 2020-06, Vol.80, p.31-41

2020

Volltextzugriff (PDF)

CYP3A53 and CYP3A422 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach

Pharmaceutics, 2023-11, Vol.15 (12), p.2699

2023

Volltextzugriff (PDF)

Development and validation of equilibrium dialysis UHPLC-MS/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma. Application to patients with HIV

Clinica chimica acta, 2024-01, Vol.552, p.117678-117678, Article 117678

2024

Volltextzugriff (PDF)

Measurement of apixaban concentrations in different human biological fluids by UHPLC-MS/MS. Clinical pharmacokinetic application in a subject with chronic kidney disease and nonvalvular atrial fibrillation on haemodialysis

Clinica chimica acta, 2023-09, Vol.549, p.117554-117554, Article 117554

2023

Volltextzugriff (PDF)

Different top-down approaches to estimate measurement uncertainty of whole blood tacrolimus mass concentration values

Clinical biochemistry, 2018-07, Vol.57, p.56-61

2018

Volltextzugriff (PDF)

Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study

Antibiotics (Basel), 2023-06, Vol.12 (7), p.1100

2023

Volltextzugriff (PDF)

Development and validation of a measurement procedure based on ultra-high performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of β-lactam antibiotic concentration in human plasma

Clinica chimica acta, 2017-05, Vol.468, p.215-224

2017

Volltextzugriff (PDF)

Measurement uncertainty and metrological traceability of whole blood cyclosporin A mass concentration results obtained by UHPLC-MS/MS

Clinical chemistry and laboratory medicine, 2018-08, Vol.56 (9), p.1458

2018

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry Method

Therapeutic drug monitoring, 2017-04, Vol.39 (2), p.102

2017

Volltextzugriff (PDF)

Measurement of total and unbound bictegravir concentrations in plasma and cerebrospinal fluid by UHPLC-MS/MS

Journal of pharmaceutical and biomedical analysis, 2020-06, Vol.185, p.113250, Article 113250

2020

Volltextzugriff (PDF)

1 – 25 von 123

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(122)
Texte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Sustained Inhibition of Calcineurin Activity With a Melt‐Dose Once‐daily Tacrolimus Formulation in Renal Transplant Recipients

Switching to bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) plus darunavir/cobicistat in heavily antiretroviral-experienced, virologically suppressed HIV-infected adults receiving complex regimens

Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy

A prospective controlled, randomized clinical trial of kidney transplant recipients developed personalized tacrolimus dosing using model-based Bayesian Prediction

Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation

The Effect of Intracellular Tacrolimus Exposure on Calcineurin Inhibition in Immediate- and Extended-Release Tacrolimus Formulations

Estimation of the uncertainty of values assigned to calibration materials prepared in-house: An example for hydroxychloroquine calibrators in blood-hemolysate-based matrix

Measurement uncertainty estimation of free drug concentrations in clinical laboratories using equilibrium dialysis

Methylprednisolone Pulses Plus Tacrolimus in Addition to Standard of Care vs. Standard of Care Alone in Patients With Severe COVID-19. A Randomized Controlled Trial

Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients

Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection

Traceability of immunosuppressant's mass concentration results obtained using different commercial calibrators

Calculation of reference intervals for the concentrations of α-tocopherol and retinol in serum using indirect data-mining procedures

Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona

Efficacy of meropenem extended infusion vs intermittent bolus monotherapy and in combination with colistin against Pseudomonas aeruginosa biofilm

Reference change values based on uncertainty models

CYP3A53 and CYP3A422 Cluster Polymorphism Effects on LCP-Tac Tacrolimus Exposure: Population Pharmacokinetic Approach

Development and validation of equilibrium dialysis UHPLC-MS/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma. Application to patients with HIV

Measurement of apixaban concentrations in different human biological fluids by UHPLC-MS/MS. Clinical pharmacokinetic application in a subject with chronic kidney disease and nonvalvular atrial fibrillation on haemodialysis

Different top-down approaches to estimate measurement uncertainty of whole blood tacrolimus mass concentration values

Voriconazole Pharmacokinetics in Critically Ill Patients and Extracorporeal Membrane Oxygenation Support: A Retrospective Comparative Case-Control Study

Development and validation of a measurement procedure based on ultra-high performance liquid chromatography-tandem mass spectrometry for simultaneous measurement of β-lactam antibiotic concentration in human plasma

Measurement uncertainty and metrological traceability of whole blood cyclosporin A mass concentration results obtained by UHPLC-MS/MS

Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry Method

Measurement of total and unbound bictegravir concentrations in plasma and cerebrospinal fluid by UHPLC-MS/MS

Suchergebnisse filtern